# Nuvation Bio Inc.: Form 8-K, filed Dec 14, 2023

- Company: [Nuvation Bio Inc.](/companies/nuvb.md) (CIK 1811063)
- Form: 8-K
- Filed: 2023-12-14
- Accepted by EDGAR: Dec 14, 2023, 16:02 ET
- Period: 2023-12-11
- Accession: 0001193125-23-295446
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1811063/000119312523295446/d66475d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1811063/000119312523295446/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1811063/000119312523295446/d66475d8k.htm

Filed Dec 14, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-295446. Last ingested by Listed: Nov 4, 2026, 17:21 ET. No prices; not investment advice.